tidytlg
A tables-listings-graphs package that reached CRAN and then went quiet.
Comparison · Analytics
daiquiri vs DoseFinding
A side-by-side editorial comparison of daiquiri and DoseFinding — release velocity, themes, recent moves, and the top alternatives to consider.
daiquiri vs DoseFinding: at a glance
What is daiquiri?
A data-quality report generator that finished its API rewrite and has been coasting on small features since.
daiquiri turns a raw clinical or administrative dataset into an HTML report of time-series data-quality plots, driven by a field-type specification the user writes. The public API settled in 2022 after a wholesale rename for rOpenSci acceptance, and releases since then have added specification conveniences rather than new report content. The 1.2.0 release is the first in nearly two years.
What is DoseFinding?
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
daiquiri vs DoseFinding: editorial side-by-side
daiquiri
0.0ANALYTICS
A data-quality report generator that finished its API rewrite and has been coasting on small features since.
◆ Current state
daiquiri turns a raw clinical or administrative dataset into an HTML report of time-series data-quality plots, driven by a field-type specification the user writes. The public API settled in 2022 after a wholesale rename for rOpenSci acceptance, and releases since then have added specification conveniences rather than new report content. The 1.2.0 release is the first in nearly two years.
◆ Where it's heading
Development has shifted from restructuring the interface to lowering the cost of using it — field_types_advanced() lets users name only the columns they care about and default the rest, which is the kind of change that matters when a dataset has hundreds of fields. Plot rendering is getting incremental attention (heatmap scaling) rather than new visualisation types. Cadence is roughly annual.
◆ Prediction
Expect the next release to continue trimming specification boilerplate for wide datasets rather than adding report sections; the entries give no indication of a new plot type or output format in progress.
DoseFinding
0.0ANALYTICS
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
◆ Current state
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
◆ Where it's heading
The pattern before the handover was maintenance — R-devel compliance, a bug fix, a link. After it, each release carries a named methodological addition with an acknowledged contributor, plus documentation to match: a longitudinal analysis vignette shipped alongside the interim power work. Housekeeping continues underneath, mostly clearing deprecated ggplot2 interfaces, aes_string in one release and qplot in the next.
◆ Prediction
Given the last two releases each added one method with a supporting vignette, expect the next to follow the same shape. Both additions so far extend the package beyond fixed dose-response fitting, so adaptive and interim methodology is the more likely direction.
Alternatives to daiquiri and DoseFinding
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either daiquiri or DoseFinding.
Tplyr
Tplyr made clinical summary tables explain where every number came from.
rlistings
Clinical listings that keep inheriting their hardest problem — pagination — from the layer below.
hoardr
A cache-directory helper that has shipped nothing but CRAN-triggered patches for seven years.
gigs
gigs redesigned its whole conversion API for rOpenSci, then spent three releases getting the docs to build.
riem
A weather-data client that keeps rewriting its HTTP layer while slowly tightening its API.
See all daiquiri alternatives → · See all DoseFinding alternatives →
Recent activity from daiquiri and DoseFinding
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
- 1y agoDoseFindingConditional and predictive power for interim analyses
- 1y agodaiquirifield_types_advanced() lets specs name only some columns
- 1y agoDoseFindingModel averaging arrives for dose-response fitting ⚡
- 1y agoDoseFindingPackage moves to openpharma under new maintainership
- 2y agoDoseFindingCompliance update for R-devel
- 3y agodaiquirift_strata() splits reports by a column's values
- 3y agoDoseFindingpowMCTBinCount bug fix
- 3y agodaiquiriColumn-order and integer-column validation fixes
- 3y agodaiquiriReport intermediates write to tempdir(), not the library
- 3y agodaiquiriFirst CRAN release
- 3y agodaiquiriPublic API renamed wholesale for rOpenSci acceptance ⚡
Frequently asked questions
What is the difference between daiquiri and DoseFinding?
They serve adjacent needs but don't currently overlap on shipped themes. daiquiri and DoseFinding are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Is daiquiri better than DoseFinding?
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. daiquiri and DoseFinding are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
What are the best alternatives to daiquiri?
Top daiquiri alternatives in Analytics are ranked by recent ship velocity. Browse the "daiquiri alternatives" section above for the current picks, or visit /alternatives/daiquiri for the full list with editorial commentary on each.
What are the best alternatives to DoseFinding?
Top DoseFinding alternatives in Analytics are ranked by recent ship velocity. Browse the "DoseFinding alternatives" section above for the current picks, or visit /alternatives/dosefinding for the full list with editorial commentary on each.